Whole-cell in vitro screening for gametocytocidal compounds

Future Medicinal Chemistry

Volumn 4, Issue 18, 2012, Pages 2337-2360

  Lucantoni, Leonardo ^a   Avery, Vicky ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOQUINOLINE DERIVATIVE; 8 AMINOQUINOLINE DERIVATIVE; 9 ANILINOACRIDINE DERIVATIVE; ANTIMALARIAL AGENT; ARTEMISININ; ARTESUNATE; ATOVAQUONE; AZITHROMYCIN; BENFLUMETOL; CHLOROQUINE; CYCLOHEXIMIDE; DIHYDROARTEMISININ; EPOXOMICIN; GREEN FLUORESCENT PROTEIN; HALOFANTRINE; HYDROXYCHLOROQUINE; MEFLOQUINE; METHYLENE BLUE; PENTAMIDINE; PIPERAQUINE; PRIMAQUINE; PYRIMETHAMINE; PYRONARIDINE; QUININE DERIVATIVE; RIBOFLAVIN; TAFENOQUINE; THIOSTREPTON; TIPRANAVIR; TRICLOSAN; UNINDEXED DRUG;

ANOPHELES; ANTIMALARIAL ACTIVITY; ASEXUAL REPRODUCTION; DISEASE TRANSMISSION; DRUG DEVELOPMENT; DRUG HALF LIFE; DRUG SCREENING; DRUG STRUCTURE; GAMETOCYTE; HIGH THROUGHPUT SCREENING; HUMAN; IC 50; IN VITRO STUDY; MALARIA; PARASITEMIA; PLASMODIUM (LIFE CYCLE STAGE); PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROTEOMICS; REVIEW; TROPHOZOITE;

ANIMALS; ANTIMALARIALS; DRUG EVALUATION, PRECLINICAL; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

EID: 84871102282     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.12.188     Document Type: Review

References (83)

1. Murray CJ, Rosenfeld LC, Lim SS et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379(9814), 413-431 (2012).
2. Aly AS, Vaughan AM, Kappe SH. Malaria parasite development in the mosquito and infection of the mammalian host. Annu. Rev. Microbiol. 63, 195-221 (2009).
3. Eastman RT, Fidock DA. Artemisinin-based combination therapies: a vital tool in efforts to eliminate. Nat. Rev. Microbiol. 7(12), 864-874 (2009).
4. Alonso PL, Brown G, Arevalo-Herrera M et al. A research agenda to underpin malaria eradication. PLoS Medicine 8(1), e1000406 (2011).
5. White NJ. The role of anti-malarial drugs in eliminating malaria. Malar. J. 7(Suppl. 1), S8 (2008).
6. Hallett RL, Sutherland CJ, Alexander N et al. Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes. Antimicrob. Agents Chemother. 48(10), 3940-3943 (2004). (Pubitemid 39304625)
7. Burrows JN, Leroy D, Lotharius J, Waterson D. Challenges in antimalarial drug discovery. Future Med. Chem. 3(11), 1401-1412 (2012).
8. Sinden RE, Smalley ME. Gametocytogenesis of Plasmodium falciparum in vitro: the cell-cycle. Parasitology 79(2), 277-296 (1979). (Pubitemid 10242529)
9. Lensen A, Bril A, Van De Vegte M, Van Gemert GJ, Eling W, Sauerwein R. Plasmodium falciparum: infectivity of cultured, synchronized gametocytes to mosquitoes. Exp. Parasitol. 91(1), 101-103 (1999). (Pubitemid 29372108)
10. Carter R, Miller LH. Evidence for environmental modulation of gametocytogenesis in Plasmodium falciparumin continuous culture. Bull. World Health Organ. 57(Suppl. 1), 37-52 (1979). (Pubitemid 10110792)
11. Farfour E, Charlotte F, Settegrana C, Miyara M, Buffet P. The extravascular compartment of the bone marrow: a niche for Plasmodium falciparum gametocyte maturation? Malar. J. 11(1), 285 (2012).
12. Alano P. Plasmodium falciparum gametocytes: still many secrets of a hidden life. Mol. Microbiol. 66(2), 291-302 (2007). (Pubitemid 47482374)
13. Silvestrini F, Tiburcio M, Bertuccini L, Alano P. Differential adhesive properties of sequestered asexual and sexual stages of Plasmodium falciparum on human endothelial cells are tissue independent. PLoS ONE 7(2), e31567 (2012).
14. Aingaran M, Zhang R, Law SK et al. Host cell deformability is linked to transmission in the human malaria parasite Plasmodium falciparum. Cell. Microbiol. 14(7), 983-993 (2012).
15. Bousema T, Okell L, Shekalaghe S et al. Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malar. J. 9, 136 (2010).
16. Karl S, Gurarie D, Zimmerman PA, King CH, St Pierre TG, Davis TM. A sub-microscopic gametocyte reservoir can sustain malaria transmission. PLoS ONE 6(6), e20805 (2011).
17. Chotivanich K, Sattabongkot J, Udomsangpetch R et al. Transmission-blocking activities of quinine, primaquine, and artesunate. Antimicrob. Agents Chemother. 50(6), 1927-1930 (2006). (Pubitemid 43807507)
18. Lanners HN. Effect of the 8-aminoquinoline primaquine on culture-derived gametocytes of the malaria parasite Plasmodium falciparum. Parasitol. Res. 77(6), 478-481 (1991).
19. Bousema JT, Schneider P, Gouagna LC et al. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J. Infect. Dis. 193(8), 1151-1159 (2006).
20. Shekalaghe S, Drakeley C, Gosling R et al. Primaquine clears submicroscopic Plasmodium falciparumgametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS ONE 2(10), e1023 (2007).
21. O'Brien C, Henrich PP, Passi N, Fidock DA. Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum. Curr. Opin. Infect. Dis. 24(6), 570-577 (2011).
22. Hedrick PW. Population genetics of malaria resistance in humans. Heredity 107(4), 283-304 (2011).
23. Kiszewski AE. Blocking Plasmodium falciparum malaria transmission with drugs: the gametocytocidal and sporontocidal properties of current and prospective antimalarials. Pharmaceuticals 4, 44-68 (2011).
24. Van Pelt-Koops JC, Pett HE, Graumans W et al. The spiroindolone drug candidate NITD609 potently inhibits gametocytogenesis and blocks Plasmodium falciparum transmission to anopheles mosquito vector. Antimicrob. Agents Chemother. 56(7), 3544-3548 (2012).
25. Aminake MN, Schoof S, Sologub L et al. Thiostrepton and derivatives exhibit antimalarial and gametocytocidal activity by dually targeting parasite proteasome and apicoplast. Antimicrob. Agents Chemother. 55(4), 1338-1348 (2011).
26. Saenz FE, Mutka T, Udenze K, Oduola AM, Kyle DE. Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro. Antimicrob. Agents Chemother. 56(9), 4685-4692 (2012).
27. Avery VM, Camp D, Carroll AR, Jenkins ID, Quinn RJ. The identification of bioactive natural products by high throughput screening (HTS). In: Comprehensive natural products II: chemistry and biology. Mander L, Lui HW (Eds). Elsevier, Oxford, 177-203 (2010).
28. Guiguemde WA, Shelat AA, Bouck D et al. Chemical genetics of Plasmodium falciparum. Nature 465(7296), 311-315 (2010).
29. Plouffe D, Brinker A, Mcnamara C et al. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proc. Natl Acad. Sci. USA 105(26), 9059-9064 (2008).
30. Gamo FJ, Sanz LM, Vidal J et al. Thousands of chemical starting points for antimalarial lead identification. Nature 465(7296), 305-310 (2010).
31. Rottmann M, Mcnamara C, Yeung BK et al. Spiroindolones, a potent compound class for the treatment of malaria. Science 329(5996), 1175-1180 (2010).
32. Trager W, Jensen JB. Human malaria parasites in continuous culture. Science 193(4254), 673-675 (1976).
33. Smalley ME. Plasmodium falciparum gametocytogenesis in vitro. Nature 264(5583), 271-272 (1976).
34. Bruce MC, Alano P, Duthie S, Carter R. Commitment of the malaria parasite Plasmodium falciparum to sexual and asexual development. Parasitology 100(Pt 2), 191-200 (1990). (Pubitemid 20168014)
35. Silvestrini F, Alano P, Williams JL. Commitment to the production of male and female gametocytes in the human malaria parasite Plasmodium falciparum. Parasitology 121(Pt 5), 465-471 (2000).
36. Baker DA. Malaria gametocytogenesis. Mol. Biochem. Parasitol. 172(2), 57-65 (2010).
37. Ifediba T, Vanderberg JP. Complete in vitro maturation of Plasmodium falciparum gametocytes. Nature 294(5839), 364-366 (1981). (Pubitemid 12202857)
38. Bennett TN, Kosar AD, Roepe PD. Plasmodium falciparum strain GC-03 exhibits hyper-gametocytogenesis in partially hemoglobin depleted red blood cells. Mol. Biochem. Parasitol. 139(2), 261-265 (2005). (Pubitemid 40128221)
39. Schneweis S, Maier WA, Seitz HM. Haemolysis of infected erythrocytes-a trigger for formation of Plasmodium falciparum gametocytes? Parasitol. Res. 77(5), 458-460 (1991).
40. Roncales M, Vidal-Mas J, Leroy D, Herreros E. Comparison and optimization of different methods for the in vitro production of Plasmodium falciparum gametocytes. J. Parasitol. Res. 927148 (2012).
41. Trager W, Gill GS, Lawrence C, Nagel RL. Plasmodium falciparum: enhanced gametocyte formation in vitro in reticulocyte-rich blood. Exp. Parasitol. 91(2), 115-118 (1999). (Pubitemid 29370087)
42. Dyer M, Day KP. Regulation of the rate of asexual growth and commitment to sexual development by diffusible factors from in vitro cultures of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 68(4), 403-409 (2003). (Pubitemid 38230638)
43. Williams JL. Stimulation of Plasmodium falciparum gametocytogenesis by conditioned medium from parasite cultures. Am. J. Trop. Med. Hyg. 60(1), 7-13 (1999). (Pubitemid 29065996)
44. Buckling A, Ranford-Cartwright LC, Miles A, Read AF. Chloroquine increases Plasmodium falciparum gametocytogenesis in vitro. Parasitology 118(Pt 4), 339-346 (1999). (Pubitemid 29186944)
45. Bousema T, Drakeley C. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin. Microbiol. Rev. 24(2), 377-410 (2011).
46. Lambros C, Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65(3), 418-420 (1979). (Pubitemid 10222999)
47. Carter R, Ranford-Cartwright L, Alano P. The culture and preparation of gametocytes of Plasmodium falciparum for immunochemical, molecular, and mosquito infectivity studies. Methods Mol. Biol. 21, 67-88 (1993).
48. Chevalley S, Coste A, Lopez A, Pipy B, Valentin A. Flow cytometry for the evaluation of anti-plasmodial activity of drugs on Plasmodium falciparum gametocytes. Malar. J. 9, 49 (2010).
49. Buchholz K, Burke TA, Williamson KC, Wiegand RC, Wirth DF, Marti M. A high-throughput screen targeting malaria transmission stages opens new avenues for drug development. J. Infect. Dis. 203(10), 1445-1453 (2011).
50. Tanaka TQ, Williamson KC. A malaria gametocytocidal assay using oxidoreduction indicator, alamarBlue. Mol. Biochem. Parasitol. 177(2), 160-163 (2011).
51. Lelievre J, Almela MJ, Lozano S et al. Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence 'transmission blocking' assay. PLoS ONE 7(4), e35019 (2012).
52. Fivelman QL, Mcrobert L, Sharp S et al. Improved synchronous production of Plasmodium falciparum gametocytes in vitro. Mol. Biochem. Parasitol. 154(1), 119-123 (2007). (Pubitemid 46879949)
53. Peatey CL, Spicer TP, Hodder PS, Trenholme KR, Gardiner DL. A high-throughput assay for the identification of drugs against late-stage Plasmodium falciparum gametocytes. Mol. Biochem. Parasitol. 180(2), 127-131 (2011).
54. Adjalley SH, Johnston GL, Li T et al. Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue. Proc. Natl Acad. Sci. USA 108(47), E1214-E1223 (2011).
55. Jungery M, Pasvol G, Newbold CI, Weatherall DJ. A lectin-like receptor is involved in invasion of erythrocytes by Plasmodium falciparum. Proc. Natl Acad. Sci. USA 80(4), 1018-1022 (1983). (Pubitemid 13118077)
56. Ponnudurai T, Lensen AH, Meis JF, Meuwissen JH. Synchronization of Plasmodium falciparum gametocytes using an automated suspension culture system. Parasitology 93( Pt 2), 263-274 (1986). (Pubitemid 16031087)
57. Karl S, Davis TM, St Pierre TG. Parameterization of high magnetic field gradient fractionation columns for applications with Plasmodium falciparum infected human erythrocytes. Malar. J. 9, 116 (2010).
58. Kariuki MM, Kiaira JK, Mulaa FK, Mwangi JK, Wasunna MK, Martin SK. Plasmodium falciparum: purification of the various gametocyte developmental stages from in vitro-cultivated parasites. Am. J. Trop. Med. Hyg. 59(4), 505-508 (1998). (Pubitemid 28480699)
59. Carter EH, Suhrbier A, Beckers PJ, Sinden RE. The in vitro cultivation of P. falciparum ookinetes, and their enrichment on Nycodenz density gradients. Parasitology 95(Pt 1), 25-30 (1987). (Pubitemid 17128904)
60. Smalley ME. Plasmodium falciparum gametocytes: The effect of chloroquine on their development. Trans. R. Soc. Trop. Med. Hyg. 71(6), 526-529 (1977).
61. Smalley ME, Sinden RE. Plasmodium falciparum gametocytes: their longevity and infectivity. Parasitology 74(1), 1-8 (1977). (Pubitemid 8016153)
62. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16(6), 710-718 (1979). (Pubitemid 10082023)
63. Makler MT, Ries JM, Williams JA et al. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am. J. Trop. Med. Hyg. 48(6), 739-741 (1993). (Pubitemid 23238452)
64. Johnson JD, Dennull RA, Gerena L, Lopez-Sanchez M, Roncal NE, Waters NC. Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Antimicrob. Agents Chemother. 51(6), 1926-1933 (2007). (Pubitemid 46903075)
65. Baniecki ML, Wirth DF, Clardy J. High-throughput Plasmodium falciparum growth assay for malaria drug discovery. Antimicrob. Agents Chemother. 51(2), 716-723 (2007). (Pubitemid 46185294)
66. Cervantes S, Prudhomme J, Carter D et al. High-content live cell imaging with RNA probes: advancements in high-throughput antimalarial drug discovery. BMC Cell Biol. 10, 45 (2009).
67. Duffy S, Avery VM. Development and optimization of a novel 384-well anti-malarial imaging assay validated for high-throughput screening. Am. J. Trop. Med. Hyg. 86(1), 84-92 (2012).
68. Lucumi E, Darling C, Jo H et al. Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay. Antimicrob. Agents Chemother. 54(9), 3597-3604 (2010).
69. Che P, Cui L, Kutsch O, Li Q. Validating a firefly luciferase-based high-throughput screening assay for antimalarial drug discovery. Assay Drug Dev. Technol. 10(1), 61-68 (2012).
70. Benoit-Vical F, Lelievre J, Berry A et al. Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes. Antimicrob. Agents Chemother. 51(4), 1463-1472 (2007). (Pubitemid 46586830)
71. Ferrer P, Tripathi AK, Clark MA, Hand CC, Rienhoff HY Jr, Sullivan DJ Jr. Antimalarial iron chelator, FBS0701, shows asexual and gametocyte Plasmodium falciparum activity and single oral dose cure in a murine malaria model. PLoS ONE 7(5), e37171 (2012).
72. Engelbrecht D, Coetzer TL. The walking dead: is hydroethidine a suitable viability dye for intra-erythrocytic Plasmodium falciparum? Parasitol. Int. 61(4), 731-734 (2012).
73. Dixon MW, Peatey CL, Gardiner DL, Trenholme KR. A green fluorescent protein-based assay for determining gametocyte production in Plasmodium falciparum. Mol. Biochem. Parasitol. 163(2), 123-126 (2009).
74. Peatey CL, Leroy D, Gardiner DL, Trenholme KR. Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes? Malar. J. 11, 34 (2012).
75. Zhang JH, Chung TD, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4(2), 67-73 (1999). (Pubitemid 29278954)
76. Sui Y, Wu Z. Alternative statistical parameter for high-throughput screening assay quality assessment. J. Biomol. Screen. 12(2), 229-234 (2007). (Pubitemid 46364419)
77. The malera consultative group on drugs: a research agenda for malaria eradication: drugs. PLoS Medicine 8(1), e1000402 (2011).
78. Mayer DC, Bruce M, Kochurova O, Stewart JK, Zhou Q. Antimalarial activity of a cis-terpenone. Malar. J. 8, 139 (2009).
79. Peatey CL, Skinner-Adams TS, Dixon MW, Mccarthy JS, Gardiner DL, Trenholme KR. Effect of antimalarial drugs on Plasmodium falciparum gametocytes. J. Infect. Dis. 200(10), 1518-1521 (2009).
80. Peatey CL, Andrews KT, Eickel N et al. Antimalarial asexual stage-specific and gametocytocidal activities of HIV protease inhibitors. Antimicrob. Agents Chemother. 54(3), 1334-1337 (2010).
81. Vale N, Moreira R, Gomes P. Primaquine revisited six decades after its discovery. Eur. J. Med. Chem. 44(3), 937-953 (2009).
82. Delves M, Plouffe D, Scheurer C et al. The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites. PLoS Medicine 9(2), e1001169 (2012).
83. Svennas KL, Macdonald SJ, Willis PA. Small molecule anti-malarial patents: a review (January 2010-June 2011). Expert Opin. Ther. Pat. 22(6), 607-643 (2012).